The discovery of IL-38 and IL-37’s potential relevance to autism came from ground-breaking research by Tsilioni and colleagues (2019, 2020), who demonstrated decreased IL-38 expression in the amygdala of children with ASD, coupled with its ability to inhibit microglial inflammatory responses. This evidence concerns the gene IL37 and autism.